Reprogram Biosciences

San Francisco, United States

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

$5.0M raised

May 2026

Seed

Biopharma Biotechnology Life Science

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reprogram Biosciences

How much funding has Reprogram Biosciences raised?

Reprogram Biosciences has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Where is Reprogram Biosciences headquartered?

Reprogram Biosciences is headquartered in San Francisco, United States.

What does Reprogram Biosciences do?

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

What stage is Reprogram Biosciences at?

Reprogram Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 26, 2026.

MLA

"Reprogram Biosciences — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/reprogram-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2026). Reprogram Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/reprogram-biosciences

Wikipedia (cite web)

{{cite web |title=Reprogram Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/reprogram-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 26, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.